Engineered CCL20 locked dimer polypeptide
The present invention provides a CCL20 locked dimer polypeptide, pharmaceutical compositions thereof, and methods of using said dimer in the treatment of psoriasis, inflammatory disorders and autoimmune disease.
1. A CCL20 locked dimer polypeptide,
wherein the dimer comprises two monomers covalently linked together,
wherein each monomer is an amino acid sequence comprising SEQ ID NO: 1.
2. A composition comprising the CCL20 locked dimer polypeptide of claim 1 , and a pharmaceutically acceptable carrier or diluent.
3. The CCL20 dimer polypeptide of claim 1 , wherein the covalent link is a disulfide bond.
4. A kit comprising a CCL20 locked dimer polypeptide wherein the dimer comprises covalently linked monomers wherein the amino acid sequence of each monomer comprises SEQ ID NO:1, a pharmaceutically acceptable carrier or diluents and instructional material.